NCT/Study#
NCT05144698 /
RAPA-201-STP-01
Phase I/II Trial of Autologous Rapamycin-Resistant Th1/Tc1 (RAPA-201) Cell Therapy of PD-(L)1 Resistant Solid Tumors
DISEASE GROUP:
Solid Tumors
current phase:
Phase I/II
STUDY STATUS:
Enrolling
Location:
Hackensack, NJ
For More information:
